Infection Control Find the newest stories covering infection and disease control in hospitals, care homes, and the general population. This section contains information on testing, monitoring, treatment options, vaccine development and distribution, as well as new policy decisions and best practices. Also included are announcements of educational and awareness campaigns. Follow new advances in infection control and prevention with releases about new study results and updated statistical data and analysis.

Latest

09:00 ET PDI Welcomes Industry-Leading Experts to Further the Advancement of its leading Infection Prevention Technology

PDI, a leader in infection prevention products and solutions, announces an exclusive relationship with two of the world's leading experts in...


08:00 ET Aptuit Announces Drug Discovery Collaboration with Massachusetts General Hospital (MGH) to Identify Novel Treatments for Gram-Negative Infections

Aptuit, LLC today announced the start of a collaboration with the Molecular Surgical Laboratory of Massachusetts General Hospital (MGH), directed...


02:00 ET Aptuit verkündet gemeinsame Arzneimittelforschung mit Massachusetts General Hospital (MGH) zur Identifizierung neuartiger Therapieansätze für gramnegative Infektionen

Aptuit, LLC, hat heute den Beginn eines Gemeinschaftsprojekts mit dem Molecular Surgical Laboratory des Massachusetts General Hospital (MGH)...


02:00 ET Aptuit annonce une collaboration portant sur la découverte de médicaments avec le Massachusetts General Hospital (MGH) pour identifier de nouveaux traitements pour les infections à bacille gram négatif

Aptuit, LLC a annoncé aujourd'hui le début d'une collaboration avec le laboratoire de chirurgie moléculaire du Massachusetts General Hospital...


02:00 ET Aptuit colaborará con el Hospital General de Massachusetts en descubrimiento de fármacos

- Aptuit anuncia una colaboración con el Hospital General de Massachusetts en descubrimiento de fármacos para identificar nuevos tratamientos...


Jan 23, 2017, 07:00 ET Oxitec and GBIT Announce Launch of Friendly™ Aedes Project in India

Gangabishan Bhikulal Investment and Trading Limited (GBIT) and Oxitec announced today the launch of the Friendly™ Aedes project in Dawalwadi,...


Jan 20, 2017, 13:37 ET South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics

A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB)...


Jan 20, 2017, 11:00 ET Huit personnes arrêtées en Guinée pour la vente illégale de médicaments antipaludiques

Le Bureau de l'inspecteur général de l'USAID agit pour arrêter le vol de marchandises financées par les États-Unis Cette semaine, une...


Jan 19, 2017, 16:25 ET 8 Arrested in Guinea for Illicit Sale of Antimalarial Drugs

This week, an investigation by the U.S. Agency for International Development (USAID) Office of Inspector General (OIG) led local authorities in...


Jan 19, 2017, 13:29 ET Ceva finalise un accord en vue du rachat du portefeuille d'anti-inflammatoires non-stéroïdiens et de vaccins Merial destinés aux porcins et aux bovins de Boehringer Ingelheim

Ceva Santé Animale a finalisé ce jour l'acquisition d'un portefeuille diversifié de produits, comprenant des vaccins destinés aux porcins et aux...


Jan 19, 2017, 12:43 ET Ceva schließt Abkommen zum Erwerb des Portfolios von Impfstoffen für Schweine und Kühe von Merial sowie nichtsteroidalen entzündungshemmenden Medikamenten von Boehringer Ingelheim ab

Nach der Akquisition von Merial Animal Health schloss Ceva Santé Animale heute die Akquisition eines vielfältigen Produktportfolios ab, zu dem...


Jan 19, 2017, 11:35 ET Ceva adquiere la cartera de vacunas de ganado porcino y vacuno de Merial

- Ceva cierra el acuerdo para adquirir la cartera de vacunas de ganado porcino y vacuno de Merial y antiinflamatorios no esteroideos de Boehringer...


Jan 19, 2017, 08:00 ET Symbiomix Therapeutics Submits New Drug Application to US FDA for Solosec™ for the Treatment of BV

Symbiomix, a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections, today announced submission...


Jan 18, 2017, 17:53 ET Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

DelveInsight's Report, "Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about...


Jan 18, 2017, 08:00 ET Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of a new test service...


Jan 17, 2017, 14:58 ET Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022

Healthcare associated infections which mainly includes hospital or community acquired infections are persisting factor in each and every healthcare...


Jan 17, 2017, 14:13 ET Hospital Acquired Infections Market Analysis & Trends-Product (Specific Hospital Acquired Infections, Disease Testing, Pseudomonas Aeruginosa,Acinetobacter Baumannii, Transmission Testing, Genotypic Methods, Drug-Resistance Testing) - Forecast to 2025

The Global Hospital Acquired Infections Testing Market is poised to grow at a CAGR of around 19.1% over the next decade to reach approximately...


Jan 17, 2017, 12:52 ET NIAID Awards Paragon Bioservices a Multiple Award IDIQ Contract valued up to $159M for Preclinical Drug Development Services

Paragon Bioservices received a multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract to provide product development services for...


Jan 17, 2017, 08:35 ET UV Disinfection Proven Effective by Newly-published Duke Health Study

The pioneer in no-touch UV disinfection has now been validated by a CDC-funded randomized clinical trial. Tru-D SmartUVC, short for "total room...


Jan 13, 2017, 08:30 ET Protecting the Public's Health: The Power of Vaccination

"As the voice of more than nearly 3,000 local health departments across the United States, the National Association of County and City Health...


Jan 12, 2017, 10:17 ET Protein Sciences Zika Vaccine Shows Good Results in Preclinical Testing

Protein Sciences Corporation, a leading vaccine development company and maker of Flublok Influenza Vaccine®, announced today that its lead protein...


Jan 11, 2017, 17:04 ET Paediatric Vaccine Market: Pneumococcal Indication Segment Anticipated to Be the Most Attractive Segment Through 2026: Global Industry Analysis and Opportunity Assessment, 2016-2026

Global Paediatric Vaccine Market: Towards a better and safer tomorrow Paediatric vaccines are administered to a child in its paediatric age which...


Jan 10, 2017, 16:16 ET La FDA insta a ampliar la participación y la diversidad en los ensayos clínicos

Los ensayos clínicos son estudios de investigación voluntarios que están diseñados para responder a preguntas específicas sobre la seguridad y...


Jan 10, 2017, 15:24 ET Rockport Healthcare Services Announces Major New Hires of Chief Medical Officer and Director of Infection Control Program

Rockport Healthcare Services, a provider of administrative and consulting services to post-acute care facilities throughout California and Texas,...


Jan 10, 2017, 09:00 ET bioLytical recognized by Premier as Breakthrough Technology Award Winner for INSTI HIV Rapid Point of Care Test

RICHMOND, BC, Jan. 10, 2017 /PRNewswire/ - bioLytical Laboratories, a world leader in rapid infectious disease tests, today announced receipt of...